Skip to content
Baker Capital StrategiesMARKETS. FILINGS. PERSPECTIVE.
Powered by THEMA

BAKER CAPITAL STRATEGIES

Get the free weekly BCS email.

Selected company filings and market updates, delivered by email. Your first report will follow soon.

  • Your weekly BCS reportMarket updates and links to filings you can explore.
  • THEMA at launchWe’ll send directions for setting up your filing alerts when THEMA officially opens.

One signup for the weekly email and your free THEMA Basic account at launch.

Already registered or a CSW member?Log in to THEMA →

At least 8 characters. This also creates your free THEMA account for launch.

You’re signing up for the weekly BCS email and THEMA launch/setup updates. Unsubscribe using the link in any email. Privacy policy · Terms

BCS

Security

BIOVENTRIX, INC. · BVXX

BVXXNASDAQCommon stockCurrentCIK 1283259Updated Oct 15, 2026

Company: BIOVENTRIX, INC. →

Name history
BIOVENTRIX INC · through Apr 4, 2023CHF TECHNOLOGIES INC · through Nov 21, 2012

BVXX price & chart

Provider market data

Loading TradingView…

NASDAQ:BVXX on TradingView ↗

TradingView · Data may be delayed

About the company

We are a medical device company focused on developing, manufacturing and commercializing proprietary devices to restore left ventricular function in heart failure patients with reduced ejection fraction (“HFrEF”).

S-1/A · 2026-05-29 · 0001493152-26-026355

Company description from the cited filing.

In the news

No coverage from other publishers is available.

Seeking Alpha

Recent filings

  1. RW filing

    RW · 2026-10-14 · 0001493152-26-046985

  2. D filing

    Items 06b

    D · 2026-10-08 · 0001283259-26-000005

  3. D/A filing

    Items 06b

    D/A · 2026-09-09 · 0001283259-26-000004

  4. D/A filing

    Items 06b

    D/A · 2026-09-01 · 0001283259-26-000003

  5. S-1/A filing

    S-1/A · 2026-05-29 · 0001493152-26-026355

Show 5 more recent filings
  1. S-1/A filing

    S-1/A · 2026-05-15 · 0001493152-26-023752

  2. D filing

    Items 06b

    D · 2026-04-24 · 0001283259-26-000002

  3. S-1/A filing

    S-1/A · 2026-03-18 · 0001493152-26-010642

  4. S-1 filing

    S-1 · 2026-02-12 · 0001493152-26-006407

  5. DRS/A filing

    DRS/A · 2025-12-12 · 0001493152-25-027406

Offerings

Registration 333-293418

S-1/A · 2026-05-29 · 0001493152-26-026355

Terms from the governing filing for this registration; not a claim that the offering is open today.

Underwriters: The Benchmark Company, LLC

Filing attachments

ex107.htm · S-1 · 2026-02-12

Exhibit 107 Calculation of Filing Fee Table S-1 (Form Type) BioVentrix, Inc. (Exact Name of Registrant as Specified in its Charter) Security Security Fee Amount Proposed Proposed Fee Amount Type …

S-1 · 2026-02-12 · 0001493152-26-006407

Read attachment ↗
ex4-1.htm · S-1 · 2026-02-12

Exhibit 4.1 THE REGISTERED HOLDER OF THIS PURCHASE WARRANT BY ITS ACCEPTANCE HEREOF, AGREES THAT IT WILL NOT SELL, TRANSFER OR ASSIGN THIS PURCHASE WARRANT EXCEPT AS HEREIN PROVIDED AND THE REGISTERED HOLDER OF THIS PURCHASE WARRANT AGREES THAT IT WILL NOT SELL, TRANSFER, ASSIGN, PLEDGE OR HYPOTHECATE THIS PURCHASE WARRANT FOR A PERIOD OF ONE HUNDRED EIGHTY DAYS FOLLOWING [ - ] [ - ], 2026 (THE “EFFECTIVE DATE”), WHICH IS THE COMMENCEMENT DATE OF SALES IN THE OFFERING (AS DEFINED BELOW) TO ANYO…

S-1 · 2026-02-12 · 0001493152-26-006407

Read attachment ↗
ex99-1.htm · S-1 · 2026-02-12

Exhibit 99.1 BIOVENTRIX, INC. FORM OF AUDIT COMMITTEE CHARTER Adopted: [__], 2026 I. Purpose. The purpose of the Audit Committee (the “ Committee ”) of the Board of Directors (the “ Board ”) of BioVentrix Inc., a Delaware corporation (the “ Corporation ”), is to assist the Board with oversight of the Corporation’s accounting and financial reporting processes and the audit of the Corporation’s financial statements. The primary role of the Committee is to oversee the Corporation’s financial…

S-1 · 2026-02-12 · 0001493152-26-006407

Read attachment ↗
ex99-2.htm · S-1 · 2026-02-12

Exhibit 99.2 BIOVENTRIX, INC. FORM OF COMPENSATION COMMITTEE CHARTER Adopted: [__], 2026 I. Purpose The Compensation Committee (“ Committee ”) of the Board of Directors (“ Board ”) of BioVentrix Inc., a Delaware corporation (“ Company ”), is appointed by the Board to: (a) assist the Board in discharging its responsibilities relating to the compensation of the Company’s directors and executive officers; and (b) produce an annual report on executive officer compensation for inclusion in the …

S-1 · 2026-02-12 · 0001493152-26-006407

Read attachment ↗

Privacy choices

BCS measures page use with Google Analytics using regional consent settings. You can change your preference here. Charts and market data remain available.

Essential functions — always available. Security, navigation, registration and remembering these choices.

Audience analytics

Analytics cookies are off by default for visitors Google identifies in the EEA, UK or Switzerland until allowed. Limited measurement without analytics cookies may still occur under those regional defaults.

TradingView charts, quotes and the economic calendar load automatically as page content. TradingView receives network and browser information and may collect its own usage analytics. This choice controls BCS’s Google Analytics only.

Google advertising is not enabled. Direct sponsor links do not load advertising trackers on BCS.

Turning analytics off stops future Google Analytics activity here. It does not erase information already received by the provider. Read the privacy policy.